Literature DB >> 21496781

[Risk-adjusted assessment: late-onset infection in neonates].

Dieter Gmyrek1, Rainer Koch, Christoph Vogtmann, Annette Kaiser, Annette Friedrich.   

Abstract

OBJECTIVE: The weak point of the countrywide perinatal/neonatal quality surveillance is the ignorance of interhospital differences in the case mix of patients. As a result, this approach does not produce reliable benchmarking. The objective of this study was to adjust the result of the late-onset infection incidence of different hospitals according to their risk profile of patients by multivariate analysis.
METHOD: The perinatal/neonatal database of 41,055 newborns of the Saxonian quality surveillance from 1998 to 2004 was analysed. Based on 18 possible risk factors, a logistic regression model was used to develop a specific risk predictor for the quality indicator "late-onset infection".
RESULTS: The developed risk predictor for the incidence of late-onset infection could be described by 4 of the 18 analysed risk factors, namely gestational age, admission from home, hypoxic ischemic encephalopathy and B-streptococcal infection. The AUC(ROC) value of this quality indicator was 83.3%, which demonstrates its reliability. The hospital ranking based on the adjusted risk assessment was very different from hospital rankings before this adjustment. The average correction of ranking position was 4.96 for 35 clinics.
CONCLUSION: The application of the risk adjustment method proposed here allows for a more objective comparison of the incidence of the quality indicator "late onset infection" among different hospitals.
Copyright © 2011. Published by Elsevier GmbH.

Entities:  

Mesh:

Year:  2011        PMID: 21496781     DOI: 10.1016/j.zefq.2011.01.001

Source DB:  PubMed          Journal:  Z Evid Fortbild Qual Gesundhwes        ISSN: 1865-9217


  1 in total

1.  Risk-adjusted intraventricular hemorrhage rates in very premature infants: towards quality assurance between neonatal units.

Authors:  Christoph Vogtmann; Rainer Koch; Dieter Gmyrek; Annette Kaiser; Annette Friedrich
Journal:  Dtsch Arztebl Int       Date:  2012-08-06       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.